Gotistobart: Clinical Trials

1 trial of Gotistobart, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Gotistobart: new trials by email Literature Review of Gotistobart trials Research Report on Gotistobart

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
ONC-392 low, ONC-392 high, lutetium Lu 177 vipivotide tetraxetan - Metastatic Castration-resistant Prostate Cancer
Phase 1 / Phase 2Active not recruitingOncoC4, Inc.1482023-12-112026-05-22

Sponsors

OncoC4, Inc. (1)

Countries

United States (1)

Top investigators

David Wise, MD (1)  ·  Mark Stein, MD (1)